maxwellt/fedgrantsembedded huggingface dataset:
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
Agency: National Institutes of Health
Posted: 2023-11-22 | Closing date: 2027-01-07
Cost sharing or matching requirement: No

The purpose of the NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) program is to support a comprehensive, rigorous biomedical research training, and dissertation research leading to a research doctorate (i.e., Ph.D.) in the biomedical, behavioral, or clinical sciences.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
National Legal and Judicial Child Welfare Center for Innovation and Advancement
Agency: Administration for Children and Families - ACYF/CB
Posted: 2024-05-03 | Closing date: 2024-07-02
Electronically submitted applications must be submitted no later than 11:59 pm Eastern Standard Time on the listed application due date.
Estimated total program funding: 3000000
Award ceiling: 3000000
Award floor: 2750000
Expected number of awards: 1
Cost sharing or matching requirement: No

The purpose of this NOFO is to establish a cooperative agreement for a National Legal and Judicial Child Welfare Center for Innovation and Advancement (Center). The Center will serve to build the capacity of the State and Tribal Court Improvement Programs (CIPs) and the broader child welfare legal and judicial communities through a variety of technical assistance (TA). The Center will support improving legal and judicial practice at different stages of child welfare, including prevention, reunification, adoption, permanency, and post-permanency. The Center will build the capacity of TA beneficiaries to meet current and future standards and requirements described in statute and federal regulations (including those specified under titles IV-B and IV-E of the Social Security Act), improve system performance, and improve outcomes for children, youth, and families. The Center will incorporate equity and continuous quality improvement (CQI) approaches throughout these efforts.

Eligibility: The Secretary may make grants to, and enter into contracts with entities that are states, Indian tribes or tribal organizations, public agencies, private agencies, or organizations (or combinations of such entities). Applications from individuals (including sole proprietorships) and foreign entities are not eligible and will be disqualified from the merit review and funding under this funding opportunity. Faith-based and community organizations that meet the eligibility requirements are eligible to receive awards under this funding opportunity. Faith-based organizations may apply for this award on the same basis as any other organization, as set forth at and, subject to the protections and requirements of 45 CFR Part 87 and 42 U.S.C. 2000bb et seq., ACF will not, in the selection of recipients, discriminate against an organization on the basis of the organization's religious character, affiliation, or exercise.
Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-21 | Closing date: 2026-02-23
Cost sharing or matching requirement: No

This NOFO provides support using the SBIR cooperative agreement mechanisms for the development of MATChS. Applications considered responsive to this would include those proposing research and development of tools and turnkey technologies for higher throughput automated measures with on-line sensing, rapid acquisition and analysis of data to reduce manual handling. Funded projects will result in an increased availability of miniaturized automated tissue chip platforms for use in drug development and across multiple applications as a major research tool in biomedical research laboratories. As a cooperative agreement, small business concerns (SBCs) will be expected to develop milestones and benchmarks, and work with NIH staff towards progress in the aims of the project to develop an automated system and demonstrable pathways to commercialization.

Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-22 | Closing date: 2026-01-27
Award ceiling: 250000
Cost sharing or matching requirement: No

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. Specifically, this FOA will support the development of exportable training modules designed to enhance training of the biomedical research workforce. Responsive topics will be indicated through Notices of Special Interest (NOSIs) released annually by NIGMS.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-22 | Closing date: 2026-11-16
Award ceiling: 350000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option).

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-22 | Closing date: 2027-01-07
Award ceiling: 450000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and incidence of FASD and (2) interventions for FASD. It is expected that research conducted via this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale FASD prevention or intervention studies. Applicants interested in exploratory phased projects may consider NOFO (TEMP-23833, the R61/R33 option).

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-24 | Closing date: 2026-11-24
Cost sharing or matching requirement: No

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision Notice of Special Interest (NOSI). Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this NOFO.

Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-11-27 | Closing date: 2026-09-05
Cost sharing or matching requirement: No

(Reissue of PAR-21-266) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.

Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Agency: National Institutes of Health
Posted: 2023-11-27 | Closing date: 2026-09-05
Cost sharing or matching requirement: No

(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application.

Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Fellowships Open Book Program
Agency: National Endowment for the Humanities
Posted: 2023-12-22 | Closing date: 2024-07-10
Estimated total program funding: 80000
Award ceiling: 6600
Award floor: 6600
Expected number of awards: 12
Cost sharing or matching requirement: No

The National Endowment for the Humanities (NEH) Office of Digital Humanities, in partnership with the NEH Division of Research Programs and Division of Education Programs, is accepting applications for the Fellowships Open Book Program. This limited competition awards publishers a $6,600 grant to release open access digital editions of books whose underlying research was funded by an eligible NEH fellowship or grant. (See NOFO section A. Program Description for a complete list of eligible programs.) Publishers must release e-books under a Creative Commons license, making those books free for anyone to download. The book could be a forthcoming title (to be open access upon first release) or it could be a book that was published, reissued, or printed in a new edition during or after calendar year 2017.

Eligibility: Eligibility is limited to publishers who have published during or after calendar year 2017 a book whose research was supported by one of the NEH programs listed under Allowable Books. Publishers must be U.S. nonprofit organizations with 501(c)(3) tax-exempt status or accredited public or 501(c)(3) institutions of higher education.
U.S. Embassy Jakarta PAS Annual Program Statement
Agency: U.S. Mission to Indonesia
Posted: 2023-11-28 | Closing date: 2024-06-30
Award ceiling: 100000
Award floor: 30000
Cost sharing or matching requirement: No

Purpose of Small Grants:The U.S. Embassy’s Public Affairs Section (PAS) in Jakarta invites proposals for projects that further and support the strategic partnership between Indonesia and the U.S. through educational, cultural, informational, and media programming that highlights shared values and promotes bilateral cooperation. All programs must include an American cultural or media-related element, or a connection with American expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives.Examples of small grants projects include but are not limited to:• Educational seminars, and expert speaker programs;• Professional and academic exchanges and projects;• Professional development workshops and training;• Artistic and cultural workshops, joint performances, and exhibitions; and• Cultural heritage conservation and preservation projects.

Eligibility: Eligible ApplicantsEmbassy Jakarta welcomes applications from:• U.S.-based and Indonesia-based non-profit organizations/nongovernment organizations (NGOs);• U.S.-based and Indonesia-based public, non-profit, private, or state institutions of higher education; and• Public International Organizations / Public Entity• Applications from organizations that include alumni of U.S. Government exchange programs are highly encouraged.For-profit or commercial entities are not eligible to apply. Individual applicants are not eligible to apply.
1. Strategic Partnership  2. Security and Defense  3. Prosperity, Trade and Investment  4. Technology and Innovation  5. Education and Human Capacity  6. Environmental Issues and Climate Crisis  7. Combating Disinformation  8. Diversity and Inclusivity
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This NOFO will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this NOFO is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P30 centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2026-07-08
Award ceiling: 225000
Cost sharing or matching requirement: No

The purpose of the Native American Research Centers for Health (NARCH) Planning Grants program is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges and universities, Tribal health programs, or Tribal organizations (collectively, eligible AI/AN Tribal entities) to plan and conduct preparatory work for developing competitive NARCH applications.

Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.   See full Notice of Funding Opportunity for additional details on eligibility.
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 300000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This NOFO will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-28 | Closing date: 2024-10-01
Award ceiling: 150000
Cost sharing or matching requirement: No

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
TARGETING THE LEARNING CRISIS
Agency: Uganda USAID-Kampala
Posted: 2023-11-29 | Closing date: 2024-11-28
Estimated total program funding: 45000000
Award ceiling: 45000000
Award floor: 3000000
Expected number of awards: 3
Cost sharing or matching requirement: No

The Uganda TLC APS seeks to engage the private and civil sectors in priority areas, as defined by the Government of Uganda (GOU) and the United States Government (USG).This initiative is designed to increase sustainability and impact of USAID/Uganda’s development assistance through civil society and non-governmental organization related partnerships in the following focus areas:1. Basic Education2. Early Childhood EducationThis APS requires submission of a five-page concept paper that answers the questions provided in SECTION D: APPLICATION AND SUBMISSION INFORMATION of the attached APS. Interested organizations must read this attachment in its entirety and follow the instructions to apply to this APS.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-29 | Closing date: 2024-10-01
Award ceiling: 300000
Cost sharing or matching requirement: No

This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer. Projects proposing application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not appropriate for this solicitation and will not be reviewed. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-29 | Closing date: 2026-11-13
Cost sharing or matching requirement: No

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-30 | Closing date: 2026-09-25
Cost sharing or matching requirement: No

The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research on a national basis. An R24 resource grant mechanism is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making timely, high quality, and cost-efficient progress in a field. Hypothesis-driven research applications should not be submitted in response to this program announcement but to another mechanism that encourages this type of research. The resource should be available to any qualified investigator, and should be highly quality controlled, and not duplicate resources available commercially or through other sources. Resources should be designed to provide services to the broad alcohol research community and should not be limited by any specific regional focus.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
F24AS00196 FY 2024 Cooperative Endangered Species Conservation Fund Traditional Conservation Grants Program Region 2
Agency: Fish and Wildlife Service
Posted: 2023-11-30 | Closing date: 2024-05-24
Electronically submitted applications must be submitted no later than 11:59 PM., ET, on the listed application due date.This program requires the submission of applications online through GrantSolutions.gov as applicants will receive an acknowledgment of application receipt.  GrantSolutions automatically generates an electronic date and time stamp in the system upon application receipt. Applicants are encouraged to verify the completeness of their application package before submission using the checklist provided below. APPLICATION CHECKLISTSF-424, Application for Federal AssistanceProject Abstract Summary FormProject NarrativeSF-424A , Budget InformationBudget NarrativeIndirect Cost Statement and related documentation (when applicable)Conflict of Interest Disclosure (when applicable)Single Audit Reporting Statement (when applicable)SF-LLL, Disclosure of Lobbying Activities (when applicable)Overlap or Duplication of Effort Statement 
Estimated total program funding: 1384372
Award ceiling: 1384372
Award floor: 1000
Cost sharing or matching requirement: Yes

The principle objective of the Traditional Conservation Grant Program is to support the development and implementation of States’ programs to conserve and recover threatened and endangered species under the Service’s jurisdiction. Financial assistance, provided in the form of grants, can be used to support projects that have direct benefits for federally listed species, candidate and at-risk species, and recently delisted species. States may apply for funding to conduct conservation work on federally-listed resident species that are included in the State’s cooperative agreement. States may also apply for funding to monitor candidate, at-risk, and recently delisted species. Projects proposed for funding may involve management, research, monitoring, and outreach activities or any combination thereof. Applications should include clear and specific information about how the proposed work would contribute to species recovery or prevent the need to list a species under the Endangered Species Act. Successful applications will be those that clearly demonstrate a direct benefit to the species or its habitat.

Eligibility: Only States agencies that have entered into a cooperative agreement with the Service pursuant to section 6(c) of the ESA or enters into/reconfirms such an agreement within 30 days of the application deadline are eligible to apply under this funding opportunity.  The Service requires a complete, signed cooperative agreement before it can obligate Federal funds to a project [50 CFR 81.3, 50 CFR 81.5, 43 CFR 12.50(b)(3)].  While funding can only be granted to States, individuals or groups (for example counties or conservation organizations) may work with a State agency that has a cooperative agreement on conservation efforts that are mutually beneficial, as a subgrantee.
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2023-11-30 | Closing date: 2026-08-19
Award ceiling: 175000
Cost sharing or matching requirement: No

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by providing research experiences and related opportunities that enrich the pool of individuals from nationally underrepresented groups who will be available to compete for research opportunities in the mission areas of importance to NHLBI. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
U.S. Embassy La Paz PD Annual Program Statement
Agency: U.S. Mission to Bolivia 
Posted: 2023-12-04 | Closing date: 2024-08-31
Rolling deadline.  However, the final submission for consideration of proposals is August 31st, 2024 as the Grants panel needs to review applications and approved proposals need to be processed before the end of the fiscal year.
Estimated total program funding: 300000
Award ceiling: 40000
Award floor: 5000
Expected number of awards: 20
Cost sharing or matching requirement: No

PD La Paz invites proposals for programs that strengthen people-to-people ties between the United States and Bolivia through cultural, educational, professional and scientific exchanges that highlight shared values and promote bilateral cooperation. All programs must include an U.S. cultural element, or connection with U.S. expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives.The PD Small Grants Program projects may include, but is not limited to:- Lectures, seminars, and speaker programs;- Artistic and cultural workshops, joint performances, and exhibitions;- Cultural heritage conservation and preservation projects;- Professional, cultural or academic exchanges and projects (including virtual exchanges with U.S. experts or communities);- Professional development workshops and training.

Eligibility: The U.S. Embassy La Paz Public Diplomacy Section encourages applications from U.S. or Bolivian citizens and/or organizations, including:• Registered public and private non-profit organizations, including think tanks and civil society/non-governmental organizations with programming experience• Individuals• Non-profit or governmental educational institutions• Governmental institutions
GEOSPATIAL INTELLIGENCE PROCESSING AND EXPLOITATION (GeoPEX)
Agency: Air Force -- Research Lab
Posted: 2023-12-11 | Closing date: 2026-09-30
For full opportunity announcement reference the SAM.gov link under Additional Information.
Award ceiling: 99900000
Cost sharing or matching requirement: No

PLEASE NOTE: No submissions through Grants.gov will be accepted. All submissions must follow SAM.gov instructions.For full opportunity announcement reference the SAM.gov link.

Eligibility: For full opportunity announcement reference the SAM.gov link under Additional Information.PLEASE NOTE: No submissions through Grants.gov will be accepted. All submissions must follow SAM.gov instructions.
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2023-11-30 | Closing date: 2025-03-20
Award ceiling: 500000
Cost sharing or matching requirement: No

Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.